Saxitoxin, the most potent voltage-gated sodium channel blocker, is one of the paralytic shellfish toxins (PSTs) produced by cyanobacteria and dinoflagellates. Recently, putative biosynthetic genes of PSTs were reported in these microorganisms. We previously synthesized genetically predicted biosynthetic intermediates, Int-A’ and Int-C’2 and also Cyclic-C’ which was not predicted based on gene and identified them all in the toxin-producing cyanobacterium Anabaena circinalis (TA04) and the dinoflagellate Alexandrium tamarense (Axat-2). This study examined the incorporation of 15N-labeled intermediates into PSTs (C1 and C2) in A. circinalis (TA04). Conversions from Int-A’ to Int-C’2, from Int-C’2 to Cyclic-C’ and from Int-A’ and Int-C’2 to C1 and C2 were indicated using high resolution-LC/MS. However, Cyclic-C’ was not converted to C1 and C2 and was detected primarily in the extracellular medium. These results suggest that Int-A’ and Int-C’2 are genuine precursors of PSTs, but Int-C’2 converts partially to Cyclic-C’ which is a shunt product excreted to outside the cells. This paper provides the first direct demonstration of the biosynthetic route towards saxitoxin and a shunt pathway.
Saxitoxin (STX, 1) (Fig. 1) and its analogues1,2, which are known as the paralytic shellfish toxins (PSTs), are strong and selective voltage-gated sodium channel (NavCh) blockers3,4. In addition to this specific biological activity, a unique tricyclic structure with two guanidines for PSTs, consisting of more heteroatoms than carbon atoms, has attracted biologists and chemists5,6,7,8,9,10. PSTs are produced by several species of freshwater cyanobacteria11,12,13,14,15,16,17,18,19,20,21 and marine dinoflagellates22,23,24,25,26, which cause serious damage to human and animal health and to seafood production worldwide. The biosynthesis of STX was first studied by Shimizu et al.27,28,29,30, who conducted feeding experiments with 13C- and/or 15N-labeled amino acids and acetic acid using the marine dinoflagellate Gonyaulax tamarensis (at present, Alexandrium tamarense) and the freshwater cyanobacterium Aphanizomenon flos-aquae. Shimizu et al.27,28,29,30 indicated that acetic acid, arginine and S-adenosyl methionine are the components to build up PSTs molecules and proposed a biosynthetic pathway towards STX, including the Claisen condensation of arginine and acetic acid. Then, Kellmann et al.31 discovered putative STX biosynthetic gene clusters (sxt) in the cyanobacterium Cylindrospermopsis raciborskii T3 and proposed a different route from Shimizu’s route based on the genetic sequences (Fig. 1). They also suggested the presence of Int-A’ (3), Int-C’ (structurally different from Int-C’2 (4)) and Int-E’ (6) (Fig. 1) in this cyanobacterium by MS/MS spectra31. Eventually, a core set of 14 genes (sxtA-sxtI, sxtP-sxtR, sxtS and sxtU) was commonly found in the PSTs-producing cyanobacteria. In the marine dinoflagellates, the presence of the similar genes possibly corresponding to PSTs biosynthesis were first reported by Stüken et al.32 in two PSTs-producing dinoflagellate strains (Alexandrium fundyense CCMP1719 and A. minutum CCMP113).
In our previous study33,34, we synthesized the genetically predicted biosynthetic intermediates proposed by Kellmann et al.31, Int-A’ (3) and Int-C’2 (4), as well as the related compound, Cyclic-C’ (7) (Fig. 1) and identified them in the PST-producing cyanobacterium Anabaena circinalis (TA04)15 and the dinoflagellate Alexandrium tamarense (Axat-2)35,36,37 using high resolution (HR)-LC/MS. These compounds were not detected in the non-PST-producing cyanobacterium Anabaena circinalis (NIES-1645)38 and dinoflagellate Alexandrium tamarense (UAT-014-009)35,36,37, supporting the suggestion that these compounds are implicated in the STX biosynthesis. However, it has not been determined that Int-A’ (3), Int-C’2 (4) and Cyclic-C’ (7) are the genuine precursors or shunt products of PSTs. In the PSTs biosynthesis, shunt pathways have not yet been reported, although they are potentially important to reduce the PSTs production. In this study, we conducted experiments to incorporate [15N2]-labeled Int-A’ (3′), Int-C’2 (4′) and Cyclic-C’ (7′) into the major STX analogues (PSTs), C1 (8) and C2 (9)39 (Fig. 2a), using A. circinalis (TA04). Furthermore, we also examined the intracellular and extracellular concentrations of these compounds to support the results of incorporation experiments.
Results and Discussion
[2,6-15N2]Arginine (2′), [2,6-15N2]Int-A’ (3′), [2,7-15N2]Int-C’2 (4′) and [3,9-15N2]Cyclic-C’ (7′) were synthesized from [2,5-15N2]L-ornithine by following the synthetic route we reported previously (Fig. 3)33,34.
[2,6-15N2]Int-A’ (3′), [2,7-15N2]Int-C’2 (4′) and [3,9-15N2]Cyclic-C’ (7′) were independently administered into the culture medium of A. circinalis (TA04) at 5 μM and cultivation was continued for 7 days. At concentrations higher than 5 μM, the cytotoxic effects of these compounds were observed in A. circinalis (TA04). In the cells cultured without labeled compounds (control), arginine (2), Int-A’ (3), Int-C’2 (4) and Cyclic-C’ (7) were detected at m/z 175.1190 (8.8 min), 187.1553 (4.7 min), 211.1666 (3.9 min) and 209.1509 (4.9 min), respectively, as the [M + H] + ions in the positive mode using HR-LC/MS (Fig. 2b). When [15N2]Int-A’ (3′) was administered, the ions at m/z 213 ([15N2]Int-C’2, 3.9 min) (4′) and at m/z 211 ([15N2]Cyclic-C’, 4.9 min) (7′) were prominently shown (Fig. 4b). This result indicated that the 15N-label from [15N2]Int-A’ (3′) was incorporated into [15N2]Int-C’2 (4′) and [15N2]Cyclic-C’ (7′) by bioconversion with the ratios of 88% and 97%, respectively, based on the peak areas. Similarly, when [15N2]Int-C’2 (4′) was administered, the intensity of the ion at m/z 211 ([15N2]Cyclic-C’, 4.9 min) (7′) clearly increased (Fig. 4c), suggesting that [15N2]Int-C’2 (4′) was converted to [15N2]Cyclic-C’ (7′) with the 15N-labeling ratio of 97%. As expected, Int-A’ (3) and Int-C’2 (4) were not 15N-labeled from [15N2]Cyclic-C’ (7′) (Fig. 4d). The conversions from [15N2]Int-A’ (3′) to [15N2]Int-C’2 (4′) and from [15N2]Int-C’2 (4′) to [15N2]Cyclic-C’ (7′) were further confirmed by the MS/MS fragmentation patterns using HR-LC-MS/MS (see Fig. S1). The possibility of decomposition of the 15N-labeled compounds administered in the medium was excluded because the arginine (2), located upstream of Int-A’ (3), Int-C’2 (4) and Cyclic-C’ (7) (Fig. 1), was not 15N-labeled and random labeling of the compounds was not suggested by the MS results. Therefore, these results supported conversion from Int-A’ (3) to Int-C’2 (4), from Int-C’2 (4) to Cyclic-C’ (7) and from Int-A’ (3) to Cyclic-C’(7) via Int-C’2 (4).
Next, incorporation of 15N-labels from [15N2]Int-C’2 (4′) and [15N2]Cyclic-C’ (7′) into PSTs (C1 (8) and C2 (9)) was examined. C1 (8) and C2 (9)39 (Fig. 2a) are the major PSTs in A. circinalis (TA04)15. These compounds are easily epimerized with each other at C-11 due to the keto-enol tautomerism of the ketone at C-1240. C2 (9) was reported to have been biosynthesized and then partially converted to C1 (8) spontaneously40. C1 (8) and C2 (9) are predicted to be derived from STX (1) in this cyanobacterium because such derivation was demonstrated in the dinoflagellate Gymnodinium catenatum41,42. Using LC/MS, C1 (8) and C2 (9) were detected at 8.2 min and 9.3 min, respectively, at m/z 474.0355 (monoisotopic ion) as the [M-H]− ion in the negative mode (Fig. 2b) due to the presence of two SO3− groups. As the preliminary test, the cells of A. circinalis (TA04) were cultured in the medium and independently administered [15N2]Int-A’ (3′), [15N2]Int-C’2 (4′), or [15N2]Cyclic-C’ (7′) at 5 μM for 16 days. Then, the 15N-labeled ratios of C1 (8) and C2 (9) were estimated based on the unlabeled (8, 9) (m/z 474) and 15N-labeled (8′, 9′) (m/z 476) peak areas on the spectra of HR-LC/MS (Fig. S2). In these estimations, the influence of the theoretical natural abundance ratio of m/z 476 to m/z 474 (12.4%) was excluded. The ratios in the samples administered [15N2]Int-A’ (3′), [15N2]Int-C’2 (4′) and [15N2]Cyclic-C’ (7′) were 4%, 6%, 0%, respectively, whereas the value of the control (without administration of any labeled compounds) was 0%. These values were too low to judge whether the labeled compounds were incorporated or not. Therefore, [15N2]Int-C’2 (4′) or [15N2]Cyclic-C’ (7′) were repetitively added to the medium of A. circinalis (TA04). A half-volume of the one-month culture of TA04 was harvested and the same volume of the fresh medium containing [15N2]Int-C’2 (4′) or [15N2]Cyclic-C’ (7′) (final concentration at 5 μM) was administered into the remaining culture approximately every 10 days for 31 days (0-, 10-, 20- or 21-day). In each harvested sample, the ratios of the relative intensities of the isotopic peak of m/z 476 to m/z 474 corresponding to C1 (8) and C2 (9) were examined and compared with each other (C2 (9): Fig. 5, C1 (8): Fig. S3). As expected, the ratios of [15N2]-labeled C1 (8′) and C2 (9′) increased at every addition of [15N2]Int-C’2 (4′) for 31 days (Fig. 5a,c and Fig. S3a,c). The [15N2]-labeled ratios of C2 (9) at 0, 10, 20 and 31 days were 0%, 11%, 13% and 17%, respectively (Fig. 5c), whereas the ratios of C1 (8) at day 0, 10, 20 and 30 were 0%, 5%, 13% and 17% (Fig. S3c), respectively. Identification of [15N2]-labeled C2 (9′) was further supported by HR-LC-MS/MS pattern that was similar to unlabeled C2 (9) (Fig. S4).
In contrast, when [15N2]Cyclic-C’ (7′) was administered to the medium repetitively, the labeled ratio of C2 (9) did not increase at all until day 31 (Fig. 5b,c), suggesting that Cyclic-C’ (7) was not converted to C2 (9). In addition, the incorporation ratio of 15N-labels from [15N2]Int-C’2 (4′) into [15N2]C2 (9′) was approximately 17% at day 31 (Fig. 5a,c), even if [15N2]Int-C’2 (4′) was administered repetitively. According to these results, we assumed that when surplus [15N2]Int-C’2 (4′) (5 μM in this experiment) was administered, [15N2]Int-C’2 (4′) was, for the most part, converted into [15N2]Cyclic-C’ (7′) (Fig. 6, route-b), which is not converted to STX analogues ([15N2]C1 (8′) and [15N2]C2 (9′)). However, a part of [15N2]Int-C’2 (4′) was converted to STX analogues (PSTs), [15N2]C1 (8′) and [15N2]C2 (9′) (Fig. 6, route-a). Thus, Cyclic-C’ (7) can be considered a shunt product. These explanations are summarized in Fig. 6.
To confirm this assumption, intracellular and extracellular concentrations of Int-A’ (3), Int-C’2 (4) and Cyclic-C’ (7) were analyzed every two days until day 10 for A. circinalis (TA04) cultured under normal conditions. As shown in Fig. 7, the concentrations of Int-A’ (3) and Int-C’2 (4) were higher in the cells than in the medium from day 2 to day 10. In contrast, the extracellular concentration of Cyclic-C’ (7) was higher than its intracellular concentration from day 4 to day 10 (Fig. 7c). In addition, the concentration of total Cyclic-C’ (7) was much higher than the concentration of total Int-C’2 (4) in all experimental periods. These results supported the above assumption that excessively administered Int-C’2 (4) (at 5 μM in this experiment) was converted to Cyclic-C’ (7) and released from the cells into the culture medium, while a small part of the administered Int-C’2 (4) was converted to PSTs (C1 (8) and C2 (9)) (Fig. 6). Thus, Cyclic-C’ (7) might be a shunt metabolite to reduce PSTs production. In PSTs non-producing dinoflagellates32,43,44 and cyanobacteria45, partial deletion of the sxtA gene or a complete lack of the sxt gene cluster have been reported as explanations for failure to produce toxin. However, to the best of our knowledge, conversion from Int-C’2 to Cyclic-C’ (7) is the first shunt pathway in PSTs producing microorganisms.
As we reported previously, the concentrations of C1 (8) and C2 (9) were much higher than the concentrations of the intermediates, 3, 4 and 7 under normal cultural conditions33,34. Indeed, the intracellular concentrations of C1 (8) and C2 (9) at day 10 in this experiment were 1.03 and 0.99 μM, respectively, whereas the intracellular concentrations of Int-A’ (3), Int-C’2 (4) and Cyclic-C’ (7) were only of the 0.1–10 nM order, as shown in Fig. 7. The result of almost complete 15N-labeling of the intermediates (4 and 7, Fig. 4) might be derived from the lower concentrations of 3, 4 and 7 than their administered concentrations (5 μM) in the starting culture. Lower 15N-labeled ratios of 8 and 9 (final 17%) were probably caused by higher concentrations of unlabeled C1 (8) and C2 (9) provided from the pre-culture in the starting culture.
We also administered 5–200 μM [15N2]arginine (2′) (Fig. 3) into the culture medium of A. circinalis (TA04) and cultured this cyanobacterium for 3–7 days under the same condition as the feeding experiments using 3′, 4′ and 7′ (see, Methods). However, Int-A’ (3), Int-C’2 (4), Cyclic-C’ (7), C1 (8) and C2 (9) were not labeled. In addition, [15N2]arginine (2′) was not detected in the cells, although unlabeled these compounds were all similarly detected as those shown in Fig. 4a. Shimizu et al. reported that [2-13C-2-15N]arginine was incorporated into saxitoxin derivatives using the cyanobacterium Aphanizomenon flos-aquae, although the experimental detail was not described30. We assume that this discrepancy was caused by the difference of the experimental condition.
The results in this study demonstrated the genetically predicted biosynthetic route to STX (1) proposed by Kellmann et al.31 and are also consistent with the results of feeding experiments reported by Shimizu et al.27,28,29,30. Several biologically important microbial shunt pathways have been reported46,47. Shunt pathways in saxitoxin biosynthesis are potentially important to reduce the PSTs productions. Although investigation of the Cyclic-C’ (7) shunt pathway in the dinoflagellate is still underway, we previously reported the presence of Cyclic-C’ (7) in the PSTs producing Alexandrium tamarense (Axat-2). Furthermore, the studies of the latter stage of the biosynthetic pathway towards PSTs are in progress using other synthetic intermediates.
In conclusion, we demonstrated that genetically predicted biosynthetic intermediates, Int-A’ (3) and Int-C’2 (4), are true precursors of PSTs (C1 (8) and C2 (9)), while Cyclic-C’ (7), which is partially converted from Int-C’2 (4), is a shunt product to be released from the cells to the outside to reduce PSTs production. This report presents the first evidence to demonstrate this route and the first finding of the shunt pathway for PSTs production. Biosynthetic steps for production of PSTs in the later stage have not been fully elucidated. This finding will accelerate efforts to clarify the full process of PSTs biosynthesis.
The isotopically labeled ornithine, [2,5-15N2]L-ornithine HCl, was purchased from Cambridge Isotope Laboratories, Inc. (Tewksbury, MA, USA). The dry solvents for organic synthesis were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). The other reagents were purchased from Sigma-Aldrich Co. (St. Louis, MO, USA), Wako Pure Chemical Industries, Ltd., Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan) and Nacalai Tesque, Inc. (Kyoto, Japan). LC/MS-grade acetonitrile (Wako Pure Chemical Industries, Ltd.) was used for LC-Q-TOF MS. Distilled and purified water (MilliQ) by Simplicity UV (Merck Millipore Corporation, Billerica, MA, USA) was used for all the experiments. NMR spectra were recorded with Agilent 600 MHz NMR spectrometer (Agilent Technologies, Inc., Santa Clara, CA, USA) with D2O or CD3OD as the solvent and internal standard. Spectra were referenced to residual solvent signals with resonances at δH = 4.79 ppm (D2O), δH/C = 3.30/49.8 ppm (CD3OD) and at δN = 0 ppm (NH3). LC/MS was performed with micrOTOF-Q II (ESI, Q-TOF) (Bruker Daltonics Inc, Billerica, MA, USA) and API2000 (AB SCIEX, Foster City, CA, USA). High resolution (HR) MS was measured with a micrOTOF-Q II (ESI). The basic culture conditions for A. circinalis (TA04) are same as we reported previously33.
Synthesis of 15N-labeled arginine (2′) and intermediates (3′, 4′, 7′)
[2,6-15N2]L-arginine (2′): 2′ was obtained as TFA salt. 1H NMR (600 MHz, D2O): δ = 4.02 (H-2, t, JH,H = 6 Hz, 1 H), 3.17 (H-5, t, JH,H = 7.2 Hz, 2 H), 1.92 (H-3, m, 2 H), 1.65 ppm (H-4, m, 2 H); 13C NMR (151 MHz, D2O): δ = 171.6 (C-1), 156.5 (C-7), 52.3 (C-2), 40.1 (C-5), 26.7 (C-3), 23.6 ppm (C-4); 15N NMR (60.8 MHz, D2O) 82.6 (N-6), 37.3 ppm (N-2); HRMS (ESI + ) (m/z): [M + H] + calcd. for C6H15N215N2O2, 177.1130; found, 177.1131.
[2,6-15N2]Int-A’ (3′): 3′ was obtained as 2 TFA salt. 1H NMR (600 MHz, CD3OD): δ = 4.15 (H-6, dd, JH,H = 7.3, 4.1 Hz, 1 H), 3.19 (H-3, t, JH,H = 6.6 Hz, 2 H), 2.65 (H-8, m, 1 H), 2.54 (H-8, m, 1 H), 2.02 (H-5, m, 1 H), 1.82 (H-5, m, 1 H), 1.67 (H-4, m, 1 H), 1.55 (H-4, m, 1 H), 1.05 ppm (H-9, t, JH,H = 7.2 Hz, 3 H); 13C NMR (151 MHz, CD3OD): δ = 208.0 (C-7), 159.6 (C-1), 60.1 (C-6), 42.5 (C-3), 34.0 (C-8), 28.7 (C-5), 26.1 (C-4), 8.3 ppm (C-9); 15N NMR (60.8 MHz, CD3OD) 81.5 (N-2), 31.8 ppm (N-6); HRMS (ESI + ) (m/z): [M + H] + calcd. for C8H19N215N2O, 189.1494; found, 189.1512.
[2,7-15N2]Int-C’2 (4′): 4′ was obtained as 2 TFA salt. 1H NMR (600 MHz, CD3OD): δ = 3.18 (H-3, t, JH,H = 6.8 Hz, 2 H), 2.53 (H-5, td, JH,H = 7.9, 2.7 Hz, 2 H), 2.47 (H-11, q, JH,H = 7.6 Hz, 2 H), 1.82 (H-4, m, 2 H), 1.17 ppm (H-12, t, JH,H = 7.5 Hz, 3 H); 13C NMR (151 MHz, CD3OD): δ = 159.5 (C-1), 148.8 (C-8), 126.1 (C-10), 121.8 (C-6), 42.2 (C-3), 30.0 (C-4), 22.1 (C-5), 16.5 (C-11), 15.0 ppm (C-12), 15N NMR (60.8 MHz, CD3OD) 133.0 (N-7), 81.5 (N-2); HRMS (ESI + ) (m/z): [M + H] + calcd. for C9H19N415N2, 213.1606; found, 213.1616.
[3,9-15N2]Cyclic-C’ (7′): 7′ was obtained as 2 formic acid salt after HPLC purification using reversed phase column. 1H NMR (600 MHz, CD3OD): δ = 3.53 (H-10, m, 1 H), 3.42 (H-10, m, 1 H), 2.39 (H-11, m, 1 H), 2.36 (H-11, m, 1 H), 2.28 (H-12, m, 1 H), 2.18 (H-12, m, 1 H), 2.12 (H-6, m, 1 H), 2.03 (H-6, m, 1 H), 1.05 (H-13, t, JH,H = 7.4 Hz, 3 H); 13C NMR (151 MHz, CD3OD): δ = 161.3 (C-2), 159.7 (C-8), 95.5 (C-4), 85.6 (C-5), 48.1 (C-10), 32.5 (C-12), 29.8 (C-6), 27.3 (C-11), 8.6 ppm (C-13), 15N NMR (60.8 MHz, CD3OD) 114.9 (N-3), 104.4 (N-9); HRMS (ESI + ) (m/z): [M + H] + calcd. for C9H17N415N2, 211.1450; found, 211.1447.
Repetitive administration of 15N-labeled intermediates and preparation of the samples for HR-LC/MS (Q-TOF)
To a 40 mL preliminary culture of A. circinalis (TA04), 40 mL of the fresh CB’ medium48 and 40 μL of 10 mM [15N2]-Int-C’2 (4′) or 10 mM [15N2]Cyclic-C’ (7′) in MeOH were independently added and cultured for 31 days. During cultivation, half of the culture (40 mL) was harvested and the fresh CB’ medium (40 mL) and 40 μL of 10 mM solutions of 4′ or 7′ were added to the remaining culture approximately every 10 days. The cells were suspended with 2.0 mL of 0.5 M AcOH and sonicated three times for 30 s on ice and the resulting solutions were centrifuged at 20,000 g for 5 min at 4 °C. The supernatants were filtered through a Cosmospin filter H (0.45 μm, Nacalai Tesque, Kyoto, Japan). The filtrates were used for two different analyses, that is, for PSTs and intermediates. A part (100 μL) of the filtrate was adjusted to pH 5 using 2 M NH3 aq and loaded on an activated charcoal column (500 μL vol.). After the column was washed with H2O, PSTs were eluted with AcOH/EtOH/H2O (5:50:45, v/v/v). The solvent was removed using N2 gas and lyophilized and the resulting residue was resuspended with 100 μL of 0.5 M AcOH as an analytical sample for PSTs. Another 100 μL of the filtrate through the Cosmospin filter H was adjusted to pH 7–8 using 2 M NH3 aq and loaded on a Cosmosil 140C18-OPN column (100 mg). After the column was washed with H2O, intermediates were eluted with AcOH/MeOH/H2O (5:50:45, v/v/v). The solvent was removed using N2 gas and lyophilized and the resulting residue was resuspended with 100 μL of 0.5 M AcOH for the analysis of intermediates.
The mass analysis was performed based on our previous reports33,34. The liquid chromatography system used for analysis was a Shimadzu Nexera UHPLC System (Shimadzu, Kyoto, Japan). The autosampler (SIL-30AC, Shimadzu) was maintained at 5 °C. Liquid chromatography was performed on a 2.1 i.d. × 150 mm (130 Å, 1.7 μm) ACQUITY UPLC BEH Amide column (Waters, Milford, MA, USA). Mobile phase A was 200 mM HCOONH4 buffer containing 200 mM HCOOH/H2O (5:95, v/v, pH 3.9) and mobile phase B was 200 mM HCOONH4 buffer containing 200 mM HCOOH/H2O /CH3CN (5:1.5:95, v/v/v). A gradient elution program was applied as follows: 0–3 min 85% B, 3–11 min 85–70% B, 11–13 min 70% B, 13–20 min 85% B. The flow rate was 0.3 mL/min. The oven temperature was 40 °C. The liquid chromatography system was connected to a Q-TOF mass spectrometer, MicrOTOF-QII (Bruker Daltonics, Billerica, MA, USA), equipped with an ESI source. The mass spectrometer conditions were as follows: positive (for Arg (2) and intermediates (3, 4, 7)) or negative (for C1 (8) and C2 (9)) ionization mode; dry gas: nitrogen at 10 L/min; dry temperature: 180 °C; nebulizer: 2.2 bar; capillary: 4500 V (for Arg and intermediates) or −4500 V (for C1 (8) and C2 (9)). The peaks for Arg (2), Int-A’ (3), Int-C’2 (4), Cyclic-C’ (7), C1 (8) and C2 (9) were detected at 8.8 min, 4.7 min, 3.9 min,4.9 min, 8.2 min and 9.3 min, respectively.
HR-LC-MS/MS for the labeled intermediates (4′, 7′) in AutoMSMS mode and C8 (9′) in MRM mode was performed in setting [M + H] + or [M-SO3 + H] + as the precursor ions. The precursor ions were m/z 213.16 for [2,7-15N2]Int-C’2 (4′) and 211.15 for [3,9-15N2]Cyclic-C’ (7′) width 4 Da and [M-SO3 + H] + m/z 398.09 and m/z 396.09 for the 15N-labeled C2 (9′) and C2 (9), respectively, width 3 Da. The sweeping collision energy was 40–120 eV for 4′ and 7′ and 15–30 eV for 9 and 9′. The mass spectrometer conditions were as follows: positive ionization mode; dry gas: nitrogen at 7.0 L/min; dry temperature: 180 °C; nebulizer: 1.6 bar; capillary: 4500 V.
The comparison of intracellular and extracellular concentrations of Int-A’ (3), IntC’2 (4) and Cyclic-C’ (7)
The preliminary culture (150 mL) was mixed with 150 mL of fresh CB’ medium to start the culture. A 30 mL culture of A. circinalis (TA04) was harvested every other day until day 10. The cells and the medium were separated by filtration using the glass fiber filter (GA100, 1.0 μm, Advantec, Tokyo, Japan). Analytical samples of the cells were prepared according to our previous report33,34. Analytical samples of the medium were prepared from the filtrates of GA100. A part of the filtrate (8 mL) was loaded on a Cosmosil 140C18-OPN (100 mg) packed in a glass pipette, which had been conditioned with MeOH and water, then washed with 2 mL of water. Int-A’ (3), Int-C’2 (4) and Cyclic-C’ (7) were eluted with 2 mL of MeOH/H2O/AcOH (50:45:5, v/v/v). The eluate was concentrated in vacuo and redissolved with 400 μL of 0.5 M AcOH. Compounds 3, 4 and 7 were quantified using the column-switching LC-MS/MS (MRM) method using API200 mass spectrometer33,34. The recoveries of 3, 4 and 7 were 48%, 37% and 73%, respectively, for this procedure, determined by the spiked medium. The final concentrations of the intermediates were calculated by considering the above recovery rates.
How to cite this article: Tsuchiya, S. et al. Biosynthetic route towards saxitoxin and shunt pathway. Sci. Rep. 6, 20340; doi: 10.1038/srep20340 (2016).
Llewellyn, L. E. Saxitoxin, a toxic marine natural product that targets a multitude of receptors. Nat. Prod. Rep. 23, 200–222 (2006).
Thottumkara, A. P., Parsons, W. H. & Du Bois, J. Saxitoxin . Angew. Chem. Int. Ed. 53, 5760–5784 (2014).
Kao, C. Y. & Nishiyama, A. Actions of saxitoxin on peripheral neuromuscular systems. J. Physiol. 180, 50–66 (1965).
Catterall, W. A. Voltage-gated sodium channels at 60: structure, function and pathophysiology. J. Physiol. 590, 2577–2589 (2012).
Tanino, H., Nakata, T., Kaneko, T. & Kishi, Y. A stereospecific total synthesis of dl-saxitoxin. J. Am. Chem. Soc. 99, 2818–2819 (1977).
Jacobi, P. A., Martinelli, M. J. & Polanc, S. Total synthesis of ( ± )-saxitoxin. J. Am. Chem. Soc. 106, 5594–5598 (1984).
Fleming, J. J. & Du Bois, J. A synthesis of ( + )-saxitoxin. J. Am. Chem. Soc. 128, 3926–3927 (2006).
Iwamoto, O., Koshino, H., Hashizume, D. & Nagasawa, K. Total synthesis of (−)-decarbamoyloxysaxitoxin. Angew. Chem. Int. Ed. 46, 8625–8628 (2007).
Bhonde, V. R. & Looper, R. E. A stereocontrolled synthesis of ( + )-saxitoxin. J. Am. Chem. Soc. 133, 20172–20174 (2011).
Sawayama, Y. & Nishikawa, T. A synthetic route to the saxitoxin skeleton: Synthesis of decarbamoyl α-saxitoxinol, an analogue of saxitoxin produced by the cyanobacterium Lyngbya wollei. Angew. Chem. Int. Ed. 50, 7176–7178 (2011).
Dittmann, E., Fewer, D. P. & Neilan, B. A. Cyanobacterial toxins: biosynthetic routes and evolutionary roots. FEMS Microbiol. Rev. 37, 23–43 (2013).
Lagos, N. et al. The first evidence of paralytic shellfish toxins in the freshwater cyanobacterium Cylindrospermopsis raciborskii, isolated from Brazil. Toxicon 37, 1359–1373 (1999).
Molica, R. et al. Toxins in the freshwater cyanobacterium Cylindrospermopsis raciborskii (Cyanophyceae) isolated from Tabocas reservoir in Caruaru, Brazil, including demonstration of a new saxitoxin analogue. Phycologia 41, 606–611 (2002).
Carmichael, W. W., Evans, W. R., Yin, Q. Q., Bell, P. & Moczydlowski, E. Evidence for paralytic shellfish poisons in the freshwater cyanobacterium Lyngbya wollei (Farlow ex Gomont) comb. nov. Appl. Environ. Microbiol. 63, 3104–3110 (1997).
Negri, A. P., Jones, G. J., Blackburn, S. I., Oshima, Y. & Onodera, H. Effect of culture and bloom development and of sample storage on paralytic shellfish poisons in the cyanobacterium Anabaena circinalis. J. Phycol. 33, 26–35 (1997).
Ballot, A., Fastner, J. & Wiedner, C. Paralytic shellfish poisoning toxin-producing cyanobacterium Aphanizomenon gracile in Northeast Germany. Appl. Environ. Microbiol. 76, 1173–1180 (2010).
Pomati, F. et al. The freshwater cyanobacterium Planktothrix sp. fp1: Molecular identification and detection of paralytic shellfish poisoning toxins. J. Phycol. 36, 553–562 (2000).
Murray, S. A., Mihali, T. K. & Neilan, B. A. Extraordinary conservation, gene loss and positive selection in the evolution of an ancient neurotoxin. Mol. Biol. Evol. 28, 1173–1182 (2011).
D’Agostino, P. M., Song, S., Neilan, B. A. & Moffitt, M. C. Comparative proteomics reveals that a saxitoxin-producing and a nontoxic strain of Anabaena circinalis are two different ecotypes. J. Proteome Res. 13, 1474–1484 (2014).
Cusick, K. D. & Sayler, G. S. An overview on the marine neurotoxin, saxitoxin: genetics, molecular targets, methods of detection and ecological functions. Mar. Drugs 11, 991–1018 (2013).
Moustafa, A. et al. Origin of saxitoxin biosynthetic genes in cyanobacteria. PLoS One 4, e5758 (2009).
Anderson, D. M. et al. The globally distributed genus Alexandrium: multifaceted roles in marine ecosystems and impacts on human health. Harmful Algae 14, 10–35 (2012).
Oshima, Y. & Yasumoto, T. Analysis of toxins in cultured Gonyaulax excavata cells originating in Ofunato Bay, Japan. In Toxic Dinoflagellates Blooms. (ed. Taylor, D. L. & Seliger, H. E. ) 377–380 (Elsevier, 1979).
Orr, R. J. S., Stüken, A., Murray, S. A. & Jakobson, K. S. Evolution and distribution of saxitoxin biosynthesis in dinoflagellates. Mar. Drugs 11, 2814–2828 (2013).
Hackett, J. D. et al. Evolution of saxitoxin synthesis in cyanobacteria and dinoflagellates. Mol. Biol. Evol. 30, 70–78 (2013).
Orr, R. J. S., Stüken, A., Murray, S. A. & Jakbsen, K. S. Evolutionary acquisition and loss of saxitoxin biosynthesis in dinoflagellates: the second “core” gene, sxtG. Appl. Environ. Microbiol. 79, 2128–2136 (2013).
Shimizu, Y., Norte, M., Hori, A., Genenah, A. & Kobayashi, M. Biosynthesis of saxitoxin analogs: the unexpected pathway. J. Am. Chem. Soc. 106, 6433–6434 (1984).
Shimizu, Y. Toxigenesis and biosynthesis of saxitoxin analogues. Pure Appl. Chem. 58, 257–262 (1986).
Gupta, S., Norte, M. & Shimizu, Y. Biosynthesis of saxitoxin analogues: the origin and introduction mechanism of the side-chain carbon. J. Chem. Soc., Chem. Commun. 19, 1421–1424 (1989).
Shimizu, Y. Microalgal metabolites. Chem. Rev. 93, 1685–1698 (1993).
Kellmann, R. et al. Biosynthetic intermediate analysis and functional homology reveal a saxitoxin gene cluster in cyanobacteria. Appl. Environ. Microbiol. 74, 4044–4053 (2008).
Stüken, A. et al. Discovery of nuclear-encoded genes for the neurotoxin saxitoxin in dinoflagellates. PLoS One 6, e20096 (2011).
Tsuchiya, S. et al. Synthesis and identification of proposed biosynthetic intermediates of saxitoxin in the cyanobacterium Anabaena circinalis (TA04) and the dinoflagellate Alexandrium tamarense (Axat-2). Org. Biomol. Chem. 12, 3016–3020 (2014).
Tsuchiya, S. et al. Synthesis of a tricyclic bisguanidine compound structurally related to saxitoxin and its identification in paralytic shellfish toxin-producing microorganisms. Chem. Eur. J. 21, 7835–7840 (2015).
Omura, T., Onodera, H., Ishimaru, T. & Oshima, Y. Non-toxic mutational sub clones in the paralytic shellfish poisoning causative dinoflagellates, Alexandrium spp. La mer. 41, 86–93 (2003).
Cho, Y. et al. Non-toxic and toxic sub clones obtained from a toxic clonal culture of Alexandrium tamarense (Dinophyceae): toxicity and molecular biological feature. Harmful Algae 7, 740–751 (2008).
Cho, Y. et al. The presence of 12β-deoxydecarbamoylsaxitoxin in the Japanese toxic dinoflagellate Alexandrium determined by simultaneous analysis for paralytic shellfish toxins using HILIC-LC-MS/MS. Harmful Algae 49, 58–67 (2015).
Watanabe, M., Niiyama, Y. & Tsuji, A. Studies on planktonic blue-green algae 10. Classification of planktonic Anabaena with coiled trichomes maintained in the National Science Museum, Tokyo. Bull. Natl. Sci. Mus. Ser. B 30, 135–149 (2004).
Wichmann, C. F. et al. Structures of two novel toxins from Protogonyaulax. J. Am. Chem. Soc. 103, 6977–6978 (1981).
Shimizu, Y. & Hsu, C. P. Confirmation of the structures of gonyautoxins I–IV by correlation with saxitoxin. J. Chem. Soc., Chem. Commun. 7, 314–315 (1981).
Sako, Y. et al. Purification and characterization of a sulfotransferase specific to N-21 of saxitoxin and gonyautoxin 2 + 3 from the toxic dinoflagellate Gymnodinium catenatum (Dinophyceae). J. Phycol. 37, 1044–1051 (2001).
Yoshida, T. et al. Purification and characterization of sulfotransferase specific to O-22 of 11-hydroxy saxitoxin from the toxic dinoflagellate Gymnodinium catenatum (dinophyceae). Fish. Sci. 68, 634–642 (2002).
Murray, S. A. et al. SxtA-based quantitative molecular assay to identify saxitoxin-producing harmful algal blooms in marine waters. Appl. Environ. Microbiol. 77, 7050–7057 (2011).
Murray, S. A. et al. A reinvestigation of saxitoxin production and sxtA in the ‘non-toxic’ Alexandrium tamarense Group V clade. Harmful Algae 18, 96–104 (2012).
Al-Tebrineh, J., Mihali, T. K., Pomati, F. & Neilan, B. A. Detection of saxitoxin-producing cyanobacteria and Anabaena circinalis in environmental water blooms by quantitative PCR. Appl. Environ. Microbiol. 76, 7836–7842 (2010).
Tarui, Y. et al. Terpendole E and its derivative inhibit STLC- and GSK-1-Resistant Eg5. ChemBioChem 15, 934–338 (2014).
Xiong, W., Brune, D. & Vermaas, S. F. J. The γ-aminobutyric acid shunt contributes to closing the tricarboxylic acid cycle in Synechocystis sp. PCC 6803. Molecular Microbiology 93, 786–796 (2014).
Watanabe, R., Suzuki, T. & Oshima, Y. Preparation of calibration standards of N1-H paralytic shellfish toxin analogues by large-scale culture of cyanobacterium Anabaena circinalis (TA04). Mar. Drugs 9, 466–477 (2011).
This work was supported by grants from the Funding Program for Next-Generation World-Leading Researchers (LS012) to M.Y.Y. and by KAKENHI Grants-in-Aid for Scientific Research to M.Y.Y. (no. 26292057) and Y.C. (no. 15K07569) from the Japan Society for the Promotion of Science (JSPS). S.T. was the recipient of a SUNBOR scholarship from the Suntory Institute for Bioorganic Research and S.T. is a research fellow of JSPS (DC2) (no. 15J00480).
The authors declare no competing financial interests.
Electronic supplementary material
About this article
Cite this article
Tsuchiya, S., Cho, Y., Konoki, K. et al. Biosynthetic route towards saxitoxin and shunt pathway. Sci Rep 6, 20340 (2016). https://doi.org/10.1038/srep20340
AI & SOCIETY (2020)
Metabolomic study of saxitoxin analogues and biosynthetic intermediates in dinoflagellates using 15N-labelled sodium nitrate as a nitrogen source
Scientific Reports (2019)
Cyanotoxins: producing organisms, occurrence, toxicity, mechanism of action and human health toxicological risk evaluation
Archives of Toxicology (2017)